Mrs
Joanna
Pownall

Patent Attorney

Manchester Office

Telephone. +44(0) 161 247 4900
Email. [email protected]

Experience

Joanna graduated from the University of Durham with a First Class MChem Honours degree in Chemistry.

In 2006 Joanna joined a major global pharmaceutical company and worked in their late-stage research and development department firstly as an analytical chemist and then as a solid state scientist. Joanna worked on a number of late stage pharmaceutical projects with multi-discipline project teams. Joanna helped define the solid state strategies, such as the selection of a suitable physical form and the control of the physical form, for a number of projects. Joanna also authored the solid state sections of regulatory submissions.

In September 2014 Joanna joined the in-house IP department of the pharmaceutical company. During her time in this department, Joanna gained experience in patent drafting and prosecution. Joanna was responsible for managing the IP portfolio of a number of early and late-stage pharmaceutical projects.

Joanna joined HGF’s Manchester office in October 2017 and has worked with a number of different clients including pharmaceutical companies and Universities. Joanna has been involved with preparing submissions for opposition and appeal proceedings before the EPO.

Specialisms

  • Pharmaceutical technologies

Industries

  • Pharmaceuticals icon Pharmaceuticals

Services

  • Patents

Qualifications

Patent Attorney

Chartered (UK)
European


MCHEM

MChem in Chemistry

Related News

EPO Enlarged Board of Appeal decision G4/19 - a European patent application can be refused by reason of the prohibition on double patenting

The European Patent Office today confirmed in Decision G4/19 of the Enlarged board of Appeal that a European patent application can be refused for ‘double patenting’.  Such a refusal can …

Read article

Managing Intellectual Property IP Stars & Firm Rankings 2021

Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …

Read article

Medical technology most patented subject matter at EPO in 2020

Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …

Read article

The EPO ‘How To’ guide for antibody applications in Europe

The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …

Read article

Personalised drug patenting in Europe

Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …

Read article

The Internet of Medical Things

Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …

Read article

Covid-19 vaccine patent waivers

To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …

Read article
Event - 9th June 2021

Webinar: Developing effective patent strategies for personalised medical devices in Europe and the US

HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.